Less than a month after securing $6M to push 3D Printing and other technologies forward, Yissum launches a platform for 3D printing of personalized medicine. The platform of the technology Transfer Company integrates a 3D printing technology that can produce drug capsules.
Professor Shlomo Magdassi, head of the Hebrew University’s 3D and Functional Printing Center, as well as a member of the Center for Nanoscience and Nanotechnology and Institute of Chemistry worked with Dr. Ofra Benny, researcher at Hebrew University’s Institute for Drug Research to develop this technology capable of 3D printing customized hydrogels with delayed release characteristics.
Until now, 3D printing of drugs has enabled the fabrication of drugs that are fast melting and whose formulation integrates a large amount of drugs in a single tablet, as seen with the 3D printing system Zipdose.
For Professoe Shlomo Magdassi and his team, in addition to customization, this approach enables the fabrication of medications out of hydrogel objects which can expand, change shape, and activate on a delayed schedule.
“Professor Magdassi and Dr. Benny’s research is an excellent example of the kind of interdisciplinary transformational inventions that originate from the Hebrew University. This technology is bringing us closer to a future in which the medical field can offer personalized, patient-centered care,” said Dr. Yaron Daniely, CEO and President of Yissum.
The technology will be showcased today at the 2nd annual conference, 3D Printing and Beyond, at the Hebrew University in Jerusalem, along with 3D printed food, automotive parts and more.
For further information, follow us on our social media and subscribe to our newsletter!
Would you like to be featured in the next issue of our digital magazine? Send us an email at contact@3dadept.com